4/A//SEC Filing
TANSEY MICHAEL JAMES BYRON 4/A
Accession 0001209191-09-006291
CIK 0000920465other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:03 PM ET
Size
5.8 KB
Accession
0001209191-09-006291
Insider Transaction Report
Form 4/AAmended
TANSEY MICHAEL JAMES BYRON
Executive VP & CMO
Transactions
- Award
Stock Option (right to buy)
2009-01-22+45,000→ 45,000 totalExercise: $1.42Exp: 2019-01-22→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock options vest and become exercisable monthly over the next four years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001369013
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:03 PM ET
- Size
- 5.8 KB